Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Amicogen Inc. (092040:KRX), powered by AI.
Amicogen Inc. is currently trading at ₩1,294. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Amicogen Inc. on Alpha Lenz.
Amicogen Inc.'s P/E ratio is -3.1.
“Amicogen Inc. trades at a P/E of -3.1 (undervalued) with modest ROE of -27.6%.”
Ask for details →Amicogen Inc. operates within the biotechnology sector, focusing on the development and production of special enzymes pivotal for pharmaceutical, food, and environmental applications. The company is renowned for its innovative approaches in enzyme engineering and bioprocessing, which are crucial for enhancing the efficiency and sustainability of various industrial processes. By leveraging its proprietary technology platform, Amicogen Inc. produces enzymes that act as catalysts in diverse chemical reactions, significantly impacting the pharmaceutical industry by improving drug synthesis and reducing production costs. Additionally, these enzymes find applications in producing healthier food products and eco-friendly solutions for waste management. In the financial market, Amicogen Inc. represents a significant player among biotech firms, contributing to advancements in green technology practices while supporting the healthcare industry's evolving needs. This aligns with global economic trends towards sustainability and innovation, enhancing its role in the market.
“Amicogen Inc. trades at a P/E of -3.1 (undervalued) with modest ROE of -27.6%.”
Ask for details →Amicogen Inc. (ticker: 092040) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 225 employees. Market cap is $91.4B.
The current price is ₩1,294 with a P/E ratio of -3.05x and P/B of 0.97x.
ROE is -27.60% and operating margin is -36.00%. Annual revenue is $42.0B.